Fighting Cancer with Gold

  • ChemPubSoc Europe Logo
  • Author: Melanie Gruß
  • Published Date: 25 February 2015
  • Source / Publisher: ChemistryOpen/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Fighting Cancer with Gold

Related Societies

Metal-based compounds have been used as chemotherapeutic drugs since the discovery of the cytotoxic properties of cisplatin (cis-[Pt(NH3)2Cl2]) in the late 1960s. Since then, it is of great interest to find drugs with a better chemotherapeutic index in terms of toxicity–activity ratio.


Dolores Fregona and colleagues, University of Padova, Italy, have synthesized two gold(III) pyrrolidinedithiocarbamates (PDT) with the general formula [AuIIIX2(PDT)] (X = Cl, Br). In vitro cytotoxicity was tested on HeLa (cervical cancer), HCT116 (colon neoplasia), SAOS (osteosarcoma), and MEF-NF1−/− (immortalized primary embryonic fibroblast) cancer cell lines.

The bromide derivative was more effective than the chloride one in inducing cell death for several cancer cell lines. The cell death-inducing mechanisms were explored by investigating whether the compounds affect redox equilibrium or influence the permeability transition pore (PTP) activity, a mitochondrial channel whose opening leads to cell death. [AuIIIBr2(PDT)] (pictured) induced oxidative stress with effects on the PTP activity.


 

Article Views: 2804

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH